1-deoxynojirimycin has been researched along with rimantadine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Codd, R; Liao, V; Lifa, T; Liu, J; Obando, D | 1 |
| Griffin, S; Harris, M; Owsianka, AM; Patel, AH; Rowlands, D; Stgelais, C | 1 |
| McKeating, JA; Meredith, LW; Zitzmann, N | 1 |
1 review(s) available for 1-deoxynojirimycin and rimantadine
| Article | Year |
|---|---|
The many faces of the adamantyl group in drug design.
Topics: Adamantane; Animals; Antimalarials; Diabetes Mellitus, Type 2; Drug Design; Humans; Hypoglycemic Agents; Iron Chelating Agents; Iron Overload; Malaria; Solubility | 2011 |
2 other study(ies) available for 1-deoxynojirimycin and rimantadine
| Article | Year |
|---|---|
Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
Topics: 1-Deoxynojirimycin; Amantadine; Amino Acid Sequence; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Neoplasms; Molecular Sequence Data; Rimantadine; Viral Proteins; Virus Replication | 2008 |
Differential effect of p7 inhibitors on hepatitis C virus cell-to-cell transmission.
Topics: 1-Deoxynojirimycin; Antiviral Agents; Cell Communication; Cell Line; Coculture Techniques; Genotype; Guanidines; Hepacivirus; Humans; Pyrazoles; Reassortant Viruses; Rimantadine; Viral Proteins; Virus Assembly; Virus Attachment; Virus Cultivation | 2013 |